Norges Bank acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 349,692 shares of the company’s stock, valued at approximately $58,175,000.
Several other institutional investors and hedge funds have also recently modified their holdings of ALAB. Assetmark Inc. lifted its stake in shares of Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Hilltop National Bank increased its stake in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. Aventura Private Wealth LLC purchased a new stake in Astera Labs in the 4th quarter worth $33,000. Wexford Capital LP bought a new stake in Astera Labs during the third quarter valued at about $39,000. Finally, National Bank of Canada FI raised its holdings in Astera Labs by 159.0% during the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares during the period. 60.47% of the stock is currently owned by institutional investors.
Astera Labs Price Performance
ALAB stock opened at $317.06 on Monday. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $372.37. The company has a fifty day simple moving average of $212.95 and a two-hundred day simple moving average of $171.81. The firm has a market capitalization of $54.35 billion, a P/E ratio of 214.23, a price-to-earnings-growth ratio of 4.20 and a beta of 3.95.
Insider Buying and Selling
In other news, CEO Jitendra Mohan sold 28,737 shares of the business’s stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the transaction, the chief executive officer owned 3,789,232 shares of the company’s stock, valued at approximately $945,868,091.84. The trade was a 0.75% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the sale, the general counsel owned 103,343 shares in the company, valued at $30,075,913.29. The trade was a 0.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 2,311,256 shares of company stock valued at $477,341,446. Insiders own 10.40% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently weighed in on ALAB. Needham & Company LLC upped their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Rothschild & Co Redburn initiated coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 target price on the stock. Morgan Stanley boosted their price target on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Susquehanna increased their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Finally, Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $233.75.
Check Out Our Latest Stock Report on Astera Labs
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
